Insiders · UTHR

Jan Malcolm

Director at UNITED THERAPEUTICS Corp (UTHR) since June 2024

Jan Malcolm has filed 13 insider reports with the SEC since June 2024, as director at UNITED THERAPEUTICS Corp (UTHR). In the last 12 months Jan Malcolm sold $348K of stock on the open market. The latest filing, on July 23, 2026, reports grant or award at UNITED THERAPEUTICS Corp (UTHR).

Filings
13
Companies
1
Bought on market
None
Sold on market
$628K

Companies where Jan Malcolm is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
UNITED THERAPEUTICS Corp logo
UTHR
UNITED THERAPEUTICS Corp
Directorsince June 2024450$628K$577.34Jul 23, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jan Malcolm with

Other insiders at the same companies

Questions about Jan Malcolm

What is Jan Malcolm's role at UNITED THERAPEUTICS Corp?
Jan Malcolm reports to the SEC as director at UNITED THERAPEUTICS Corp (UTHR), according to the latest filing on July 23, 2026.
How many shares does Jan Malcolm own?
After the latest filing that states it, Jan Malcolm directly owned 450 shares of UNITED THERAPEUTICS Corp (UTHR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jan Malcolm bought or sold stock recently?
The most recent open-market sale was on July 10, 2026: sold 325 shares of UNITED THERAPEUTICS Corp (UTHR) for $179K at an average of $550.59.
How do I get alerts when Jan Malcolm files?
Follow Jan Malcolm on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jan Malcolm (SEC CIK 0002028640). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2024 on. View on SEC EDGAR